GO:0033484 intracellular nitric oxide homeostasis: Signaling Balance, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033484 intracellular nitric oxide homeostasis describes the biological process that maintains a steady-state level of nitric oxide (NO) inside a cell.
• NO is a short-lived, membrane-permeable free radical that acts as a signaling molecule, and its intracellular concentration must be tightly controlled to avoid toxicity.
• Key proteins involved include nitric oxide synthases (NOS1, NOS2, NOS3), heme oxygenase-1 (HMOX1), VDAC1, and mitochondrial electron transport chain components.
• Disrupted NO homeostasis is linked to acute kidney injury, myocardial ischemia/reperfusion injury, neurodegeneration, and melanocyte apoptosis.
• Experimental models for studying this process include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening.
• Understanding intracellular NO homeostasis is essential for developing therapies that target NO signaling in cardiovascular, renal, and neurological diseases.
Description
Intracellular nitric oxide homeostasis (GO:0033484) is the biological process that maintains a steady-state level of nitric oxide (NO) within a cell. NO is a gaseous free radical that serves as a signaling molecule in diverse physiological processes, including vasodilation, neurotransmission, and immune defense. Because NO is highly reactive and can diffuse freely across membranes, its intracellular concentration must be precisely regulated to prevent oxidative damage and to ensure proper signal transduction. The QuickGO definition states that this process is involved in the maintenance of a steady state level of nitric oxide within a cell. Researchers study this term to understand how cells balance NO production, scavenging, and downstream signaling, and how dysregulation contributes to disease. The importance of intracellular NO homeostasis extends to both health and disease. In the cardiovascular system, NO produced by endothelial nitric oxide synthase (NOS3) regulates vascular tone, and its imbalance is associated with myocardial ischemia/reperfusion injury. In the kidney, NO-primed extracellular vesicles can restore bioenergetics and protect against acute kidney injury. In the nervous system, altered NO homeostasis is implicated in neurodegenerative diseases such as Alzheimer's disease. Furthermore, NO homeostasis intersects with iron metabolism, calcium signaling, and mitochondrial function, highlighting its central role in cellular physiology. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0033484, covering its definition, mechanisms, key genes, disease associations, and research methodologies.
intracellular nitric oxide homeostasis At A Glance
| GO ID | GO:0033484 |
|---|---|
| GO term | intracellular nitric oxide homeostasis |
| Ontology | biological_process |
| Synonym | cellular nitric oxide homeostasis; nitric oxide homeostasis; NO homeostasis |
| Definition | A homeostatic process involved in the maintenance of a steady state level of nitric oxide within a cell. |
| Major function | Maintains steady-state intracellular NO levels for signaling and prevents nitrosative stress. |
| Key enzymes | Nitric oxide synthases (NOS1, NOS2, NOS3), heme oxygenase-1 (HMOX1) |
| Related processes | Calcium homeostasis, iron homeostasis, mitochondrial function, apoptosis |
What Is GO:0033484?
Intracellular nitric oxide homeostasis (GO:0033484) is defined by QuickGO as a homeostatic process involved in the maintenance of a steady state level of nitric oxide within a cell. In simpler terms, it is the cellular machinery that keeps the amount of NO just right: not too much, which can cause oxidative stress and damage, and not too little, which would impair signaling. This process encompasses the synthesis of NO by nitric oxide synthases, its diffusion and reaction with targets, and its removal or scavenging by antioxidants and other molecules. It is a biological process that ensures NO can function as a reliable signaling molecule while minimizing its toxic potential.
Why Is intracellular nitric oxide homeostasis Important in Cell Biology?
Intracellular nitric oxide homeostasis is critical because NO is a double-edged sword: at physiological levels it acts as a key signaling molecule in cardiovascular, nervous, and immune systems, but at excessive or insufficient levels it contributes to disease pathogenesis. Maintaining NO homeostasis is essential for normal cellular function, and its disruption is associated with a wide range of pathologies, including acute kidney injury, myocardial ischemia/reperfusion injury, neurodegeneration, and melanocyte apoptosis. Therefore, understanding the molecular mechanisms that regulate intracellular NO levels is vital for developing targeted therapies.
• Regulates vascular tone and blood pressure through endothelial NO signaling.
• Protects against ischemia/reperfusion injury in the heart by maintaining mitochondrial function.
• Supports kidney function and recovery from acute kidney injury via NO-primed extracellular vesicles.
• Modulates calcium homeostasis and prevents apoptosis in melanocytes.
• Interacts with iron homeostasis and oxidative stress responses in plants and mammals.
• Influences neurodegenerative disease progression, including Alzheimer's disease.
• Maintains microbial NO homeostasis and signaling in bacteria such as Streptomyces coelicolor.
• Serves as a target for therapeutic interventions in cardiovascular, renal, and neurological disorders.
What Happens During intracellular nitric oxide homeostasis?
Nitric Oxide Synthesis
In simple terms: The cell makes NO using specialized enzymes called nitric oxide synthases.
Nitric oxide is synthesized from L-arginine by a family of enzymes known as nitric oxide synthases (NOS). There are three main isoforms: neuronal NOS (NOS1), inducible NOS (NOS2), and endothelial NOS (NOS3). These enzymes convert L-arginine to L-citrulline and NO in a reaction that requires oxygen and NADPH. The activity of NOS is tightly regulated by calcium/calmodulin and by post-translational modifications. In the context of intracellular NO homeostasis, synthesis must be balanced with removal to prevent toxic accumulation. For example, L-arginine-loaded gold nanocages have been shown to promote NO production and maintain mitochondrial function in myocardial ischemia/reperfusion injury.
Nitric Oxide Diffusion and Signaling
In simple terms: Once made, NO quickly spreads within and between cells to deliver signals.
Because NO is a small, uncharged gas, it can diffuse freely across cell membranes and reach targets in neighboring cells. Inside the cell, NO binds to the heme group of soluble guanylate cyclase (sGC), triggering the production of cyclic GMP (cGMP), which then activates protein kinase G (PKG) and downstream signaling pathways. NO also modulates calcium homeostasis by regulating calcium channels and transporters, as demonstrated in human primary melanocytes where NO induces apoptosis via VDAC1 and calcium dysregulation. This signaling must be transient and controlled to avoid sustained nitrosative stress.
Nitric Oxide Scavenging and Removal
In simple terms: The cell eliminates excess NO to keep its levels safe.
To maintain homeostasis, cells remove NO through reactions with reactive oxygen species, metal centers, and antioxidants such as glutathione and mycothiol. In bacteria, mycothiol maintains the homeostasis and signaling of NO in Streptomyces coelicolor. In mammalian cells, heme oxygenase-1 (HMOX1) plays a role in NO homeostasis by degrading heme, which is a cofactor for NOS, and by producing biliverdin and carbon monoxide, which can modulate NO levels. Additionally, NO can react with superoxide to form peroxynitrite, a toxic species, so scavenging systems are essential to prevent cellular damage.
Integration with Mitochondrial Function
In simple terms: NO levels are closely tied to how well mitochondria work.
Mitochondria are both sources and targets of NO. Mitochondrial NO can inhibit cytochrome c oxidase, affecting respiration and ATP production. Conversely, mitochondrial dysfunction can lead to increased reactive oxygen species that consume NO. In acute kidney injury, NO-primed engineered extracellular vesicles restore bioenergetics via mitochondrial transfer, highlighting the interplay between NO homeostasis and mitochondrial health. Similarly, in myocardial ischemia/reperfusion injury, promoting NO production helps maintain mitochondrial function and reduces damage.
Crosstalk with Iron and Calcium Homeostasis
In simple terms: NO balance is linked to how cells handle iron and calcium.
Intracellular NO homeostasis is interconnected with iron and calcium homeostasis. In plants, NO plays a role in iron homeostasis under oxidative stress, and heme oxygenase-nitric oxide crosstalk mediates iron balance. In human melanocytes, NO regulates calcium homeostasis via VDAC1, and disruption leads to apoptosis. These examples illustrate that NO homeostasis is not an isolated process but is integrated into a network of cellular homeostatic mechanisms.
Key Genes Involved in GO:0033484 intracellular nitric oxide homeostasis
The following genes and proteins are central to the regulation and maintenance of intracellular nitric oxide homeostasis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOS1 | Neuronal nitric oxide synthase; produces NO in neurons | Studied in neurotransmission and neurodegeneration |
| NOS2 | Inducible nitric oxide synthase; produces NO in immune responses | Target in inflammation and host defense |
| NOS3 | Endothelial nitric oxide synthase; produces NO in endothelium | Key regulator of vascular tone; studied in cardiovascular disease |
| HMOX1 | Heme oxygenase-1; degrades heme and modulates NO levels | Linked to iron homeostasis and oxidative stress |
| VDAC1 | Voltage-dependent anion channel 1; regulates calcium and NO-induced apoptosis | Studied in melanocyte apoptosis and calcium homeostasis |
| GUCY1A1 | Soluble guanylate cyclase subunit; NO receptor | Mediates NO signaling via cGMP |
| GUCY1B1 | Soluble guanylate cyclase subunit; NO receptor | Mediates NO signaling via cGMP |
| ARG1 | Arginase 1; competes with NOS for L-arginine | Regulates NO synthesis by limiting substrate |
| ARG2 | Arginase 2; mitochondrial arginase | Modulates NO production in mitochondria |
| SLC7A1 | Cationic amino acid transporter; imports L-arginine | Affects NO synthesis by controlling substrate availability |
| SLC7A2 | Cationic amino acid transporter; imports L-arginine | Affects NO synthesis by controlling substrate availability |
| MYC | Transcription factor; regulates NOS2 expression | Influences NO production in cancer and inflammation |
| NFKB1 | Transcription factor; induces NOS2 | Mediates inflammatory NO production |
| HIF1A | Hypoxia-inducible factor 1-alpha; regulates NOS2 and NOS3 | Links oxygen sensing to NO homeostasis |
| KEAP1 | Regulator of NRF2; affects antioxidant response and NO scavenging | Modulates oxidative stress and NO levels |
| NFE2L2 | NRF2; transcription factor for antioxidant genes | Protects against nitrosative stress |
| MSRA | Methionine sulfoxide reductase A; repairs oxidized proteins | May protect against NO-induced oxidative damage |
How Is intracellular nitric oxide homeostasis Regulated?
Intracellular nitric oxide homeostasis is regulated at multiple levels. Transcriptionally, NOS genes are controlled by factors such as NF-κB, HIF-1α, and MYC, which respond to inflammatory and hypoxic stimuli. Post-translationally, NOS activity is modulated by phosphorylation, calcium/calmodulin binding, and subcellular localization. Substrate availability is regulated by L-arginine transporters and arginases, which compete with NOS for L-arginine. Additionally, NO levels are buffered by scavengers such as glutathione, mycothiol, and heme oxygenase-1. The interplay between NO and calcium signaling further fine-tunes its effects, as seen in melanocytes where VDAC1 regulates calcium and NO-induced apoptosis. In plants, NO homeostasis is integrated with iron metabolism and oxidative stress responses.
intracellular nitric oxide homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOS3 | Cardiovascular disease, hypertension | Knockout and overexpression cell lines |
| VDAC1 | Melanocyte apoptosis, calcium dysregulation | Point mutation and knockout models |
| HMOX1 | Iron homeostasis, oxidative stress | Knockout and knock-in models |
| NOS2 | Inflammation, cancer | Overexpression and knockout models |
| GUCY1A1 | NO signaling disorders | Point mutation models |
Acute Kidney Injury
Disruption of intracellular NO homeostasis contributes to acute kidney injury (AKI). NO-primed engineered extracellular vesicles have been shown to restore bioenergetics in AKI via mitochondrial transfer, suggesting that maintaining NO levels is protective. This highlights the therapeutic potential of targeting NO homeostasis in renal diseases.
Myocardial Ischemia/Reperfusion Injury
In myocardial ischemia/reperfusion injury, reduced NO bioavailability impairs mitochondrial function and exacerbates tissue damage. L-arginine-loaded gold nanocages ameliorate this injury by promoting NO production and maintaining mitochondrial function. Thus, strategies to enhance intracellular NO homeostasis may be cardioprotective.
Neurodegenerative Diseases
Altered NO homeostasis is implicated in neurodegenerative diseases such as Alzheimer's disease. Excessive NO can lead to nitrosative stress and neuronal damage, while insufficient NO impairs neurotransmission and blood flow. Understanding NO homeostasis in the brain is crucial for developing neuroprotective therapies.
Melanocyte Apoptosis and Skin Disorders
In human primary melanocytes, NO induces apoptosis by regulating calcium homeostasis via VDAC1. This suggests that dysregulated NO homeostasis may contribute to pigmentary disorders and melanocyte loss. Targeting NO signaling could offer new approaches for treating such conditions.
From intracellular nitric oxide homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NOS3 affect NO homeostasis and vascular function? | NOS3 knockout cell line |
| How does a specific point mutation in VDAC1 alter NO-induced apoptosis? | VDAC1 point-mutation knock-in cell line |
| Can overexpression of HMOX1 restore NO homeostasis under oxidative stress? | HMOX1 overexpression cell line |
| What is the role of NOS2 in inflammatory NO production? | NOS2 knockout and overexpression models |
| How does NO homeostasis affect mitochondrial function? | Mitochondria-targeted NO sensors and knockout models |
| Can CRISPR library screening identify novel regulators of NO homeostasis? | Genome-wide CRISPR knockout library screening |
How to Study the intracellular nitric oxide homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| DAF-FM DA staining | Intracellular NO levels | Live-cell imaging of NO production |
| Griess assay | Nitrite/nitrate as NO metabolites | Quantification of NO release |
| CRISPR knockout | Gene function loss | Studying NOS3, VDAC1 in NO homeostasis |
| CRISPR knock-in | Specific mutations | Modeling point mutations in NO-related genes |
| Western blot | Protein expression of NOS isoforms | Assessing NOS regulation |
| qPCR | mRNA levels of NO-related genes | Transcriptional regulation studies |
| Seahorse assay | Mitochondrial respiration | Linking NO to bioenergetics |
| S-nitrosylation proteomics | Protein S-nitrosylation | Identifying NO targets |
Measuring Intracellular NO Levels
Intracellular NO can be measured using fluorescent probes such as DAF-FM DA or Griess reagent for nitrite/nitrate. These methods allow real-time monitoring of NO production and homeostasis in live cells.
Genetic Manipulation with CRISPR
CRISPR/Cas9 technology enables the generation of knockout, point-mutation, and knock-in cell models to study the function of genes involved in NO homeostasis. For example, knocking out NOS3 or VDAC1 can reveal their roles in NO signaling and apoptosis.
Proteomics and Metabolomics
Mass spectrometry-based proteomics and metabolomics can identify proteins and metabolites associated with NO homeostasis, such as S-nitrosylated proteins and arginine metabolites.
Imaging and Live-Cell Analysis
Live-cell imaging with NO-sensitive dyes and genetically encoded sensors (e.g., geNOps) allows spatial and temporal tracking of NO dynamics within cells and organelles.
How CRISPR Can Be Used to Study GO:0033484 intracellular nitric oxide homeostasis
Knockout
CRISPR knockout of genes such as NOS3, NOS2, or VDAC1 can abolish NO production or signaling, allowing researchers to study the consequences for intracellular NO homeostasis. For example, NOS3 knockout cells show impaired NO synthesis and altered vascular function.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants in genes like VDAC1 or GUCY1A1. These models help dissect the precise molecular mechanisms by which specific amino acid changes affect NO homeostasis and downstream signaling.
Knock-in
Knock-in of tagged or reporter genes (e.g., GFP-NOS3) allows real-time visualization of protein localization and dynamics. This is useful for tracking NOS trafficking and its impact on NO homeostasis.
Overexpression
Overexpression of genes such as HMOX1 or NOS3 can enhance NO production or scavenging, providing insights into how increased levels affect cellular homeostasis. This approach is valuable for testing therapeutic strategies that aim to boost NO signaling.
How EDITGENE Supports intracellular nitric oxide homeostasis Research
Researchers studying intracellular nitric oxide homeostasis-related genes often need to determine whether a candidate gene is causally involved in maintaining NO balance or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes implicated in GO:0033484.
Contact EDITGENE today to design your custom CRISPR model for intracellular nitric oxide homeostasis research.
Frequently Asked Questions About intracellular nitric oxide homeostasis
What is intracellular nitric oxide homeostasis?
Intracellular nitric oxide homeostasis (GO:0033484) is the biological process that maintains a steady-state level of nitric oxide within a cell, ensuring proper signaling while preventing toxicity.
What genes are involved in intracellular nitric oxide homeostasis?
Key genes include NOS1, NOS2, NOS3, HMOX1, VDAC1, GUCY1A1, GUCY1B1, ARG1, ARG2, and SLC7A1, among others.
How is nitric oxide produced in cells?
Nitric oxide is produced from L-arginine by nitric oxide synthases (NOS1, NOS2, NOS3) in a reaction requiring oxygen and NADPH.
Why is nitric oxide homeostasis important?
It is crucial for cardiovascular, nervous, and immune functions, and its disruption is linked to diseases such as acute kidney injury, myocardial ischemia/reperfusion injury, and neurodegeneration.
What diseases are associated with disrupted nitric oxide homeostasis?
Diseases include acute kidney injury, myocardial ischemia/reperfusion injury, Alzheimer's disease, and melanocyte apoptosis disorders.
How can I study intracellular nitric oxide homeostasis?
You can use fluorescent probes, CRISPR knockout/knock-in models, proteomics, and live-cell imaging to measure NO levels and manipulate related genes.
What is the role of VDAC1 in nitric oxide homeostasis?
VDAC1 regulates calcium homeostasis and is involved in NO-induced apoptosis in human melanocytes.
How does heme oxygenase-1 relate to nitric oxide homeostasis?
HMOX1 degrades heme, affecting NOS cofactor availability and modulating NO levels, and is linked to iron homeostasis.
Can CRISPR be used to study nitric oxide homeostasis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in NO homeostasis.
What services does EDITGENE offer for nitric oxide research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services tailored to NO homeostasis research.
Conclusion
Intracellular nitric oxide homeostasis (GO:0033484) is a fundamental biological process that balances NO synthesis, signaling, and scavenging to maintain cellular health. Its dysregulation contributes to a variety of diseases, including acute kidney injury, cardiovascular disorders, and neurodegeneration. Advances in CRISPR-based models and analytical methods are enabling researchers to dissect the molecular players and pathways involved. EDITGENE offers comprehensive services to support these studies, from custom cell line generation to high-throughput screening and bioinformatics.
References
- 1. Peng F et al.. 2025. Nitric oxide-primed engineered extracellular vesicles restore bioenergetics in acute kidney injury via mitochondrial transfer.. Theranostics 15(11):5499-5517 PMID: 40303326
- 2. Singh N et al.. 2022. Heme oxygenase-nitric oxide crosstalk-mediated iron homeostasis in plants under oxidative stress.. Free Radic Biol Med 182:192-205 PMID: 35247570
- 3. Lu J et al.. 2025. Nitric oxide induces apoptosis of human primary melanocytes by regulating calcium homeostasis via VDAC1.. Mol Cell Biochem 480(12):6111-6125 PMID: 40753527
- 4. Clementi E. 1998. Role of nitric oxide and its intracellular signalling pathways in the control of Ca2+ homeostasis.. Biochem Pharmacol 55(6):713-8 PMID: 9586942
- 5. Tewari RK et al.. 2021. Evidence for a role of nitric oxide in iron homeostasis in plants.. J Exp Bot 72(4):990-1006 PMID: 33196822
- 6. Wang Z et al.. 2023. L-Arginine-Loaded Gold Nanocages Ameliorate Myocardial Ischemia/Reperfusion Injury by Promoting Nitric Oxide Production and Maintaining Mitochondrial Function.. Adv Sci (Weinh) 10(26):e2302123 PMID: 37449329
- 7. Hannibal L. 2016. Nitric Oxide Homeostasis in Neurodegenerative Diseases.. Curr Alzheimer Res 13(2):135-49 PMID: 26391043
- 8. Yoshizumi T et al.. 2023. Mycothiol maintains the homeostasis and signalling of nitric oxide in Streptomyces coelicolor A3(2) M145.. BMC Microbiol 23(1):285 PMID: 37798648
